Discover
COGT
Cogent Biosciences, Inc.
39.64
1 x 28.00
1 x 40.12
bid
ask
+
1.34
3.50%
80 @ 04:00 PM
39.48 -0.16 (0.40%)
| Ytd | 11.60% | |
| 1y | 218.39% |
38.22
day range
39.80
10.38
52 week range
43.73
| Open | 38.22 | Prev Close | 38.30 | Low | 38.22 | High | 39.80 | Mkt Cap | 6.77B |
| Vol | 1.29M | Avg Vol | 2.39M | EPS | -2.11 | P/E | -18.79 | Forward P/E | -40.67 |
| Beta | 0.34 | Short Ratio | 4.99 | Inst. Own | 113.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 35.44 | 200-d Avg | 33.76 | 1yr Est | 54.25 |
COGT News
benzinga.com
Cogent Biosciences Files New Drug Application To FDA For Bezuclastinib In Advanced Systemic Mastocyt
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision the
benzinga.com
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application
FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 20
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Oth
benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 647 companies set new 52-week lows.